Vasculitis in primary connective tissue diseases

Size: px
Start display at page:

Download "Vasculitis in primary connective tissue diseases"

Transcription

1 Oxford Medicine Online You are looking at 1-10 of 26 items for: MRI rheumatoid MED00240 Vasculitis in primary connective tissue diseases Laura B. Hughes DOI: /med/ Vasculitis occurring in the context of connective tissue diseases (including rheumatoid arthritis, Sjögren s syndrome, systemic sclerosis, systemic lupus erythematosus, polychondritis, seronegative spondyloarthropathies, idiopathic inflammatory myopathies, aortitis, periaortitis, and idiopathic retroperitoneal fibrosis) presents difficult diagnostic challenges due to the variety of vessels and organ systems that can be involved, and the range in degree of severity. Vasculitis in connective tissue diseases is often associated with more severe disease activity and longer disease duration. Fortunately, most are responsive to currently available therapies, especially when the diagnosis is made and appropriate therapy instituted in a timely fashion. The most important factors in successfully making these diagnoses are familiarity with common patterns of vasculitis within a given disease process and vigilance for the identification of vasculitis in the differential diagnosis. Imaging in psoriatic arthritis Dafna D. Gladman, Cheryl F. Rosen, and Vinod Chandran Print Publication Year: 2014 Published Online: Apr 2014 ISBN: eisbn: DOI: /med/ Imaging is important to determine the degree and severity of joint and entheseal inflammation Radiographic evidence of peripheral joint damage includes erosions, joint space narrowing, juxta-articular fluffy periostitis, severe osteolysis, pencil-in-cup change, ankylosis and subluxation. Axial radiographs often reveal sacroiliitis, syndesmophytes (marginal or paramarginal), facet joint fusion, discitis, and occasionally atlanto-axial subluxation Ultrasonography may be used to detect inflammatory and destructive changes in joints, tendons, and entheses, especially at point of care Magnetic resonance imaging is especially useful to demonstrate early peripheral joint damage as well as axial inflammation Page 1 of 5

2 Cutaneous vasculitis, connective tissue diseases, and urticaria Susan Burge and Graham S. Ogg Print Publication Year: 2010 Published Online: Nov 2013 ISBN: eisbn: DOI: /med/ _update_001 Vasculitis (angiitis) denotes necrotizing inflammation of the blood vessels; occlusive vasculopathy implies vascular occlusion without significant vascular inflammation. A small-vessel cutaneous vasculitis is the most common vasculitis affecting the skin, and may be the first sign of a systemic vasculitis, but 50% of patients have no systemic disease. The clinical findings must be integrated with the results of serological, pathological, and imaging studies to reach a diagnosis... Vasculitic manifestations in the gastrointestinal tract Gaafar Ragab DOI: /med/ Early diagnosis and prompt management of vasculitic lesions in the gastrointestinal (GI) tract is essential to avoid its potentially serious sequelae. In order to better understand the manifestations and consequences of vasculitic lesions in the GI tract, and the different approaches to diagnosis, the chapter presents a brief review of the anatomy and physiology of the GI tract. The recent developments in our understanding of the human gut microbiome is also discussed, as this is expected to contribute to our knowledge of the role of the GI tract in autoimmunity. This is followed by an outline of the various pathogenic mechanisms causing bowel ischaemia, the manifestation of vasculitis in the GI tract, and the use of imaging in diagnosis, and a discussion of the wide differential diagnosis-an important topic in the setting of suspected of acute GI vasculitis. Finally, an outline is given of GI involvement in the specific vasculitides. Cross-sectional imaging in vasculitis Enrique A. Sabater and Anthony W. Stanson DOI: /med/ While angiography demonstrates high-resolution images of blood vessel lumens, one of its main limitations is the inability to demonstrate disease occurring in the vessel wall where the primary pathological changes of vasculitis occur. More importantly, mural findings may precede luminal abnormalities and, indeed, luminal changes may never be evident. Thus, the non-invasive, cross-sectional imaging modalities of ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI) have important roles in the diagnosis of vasculitis and in treatment follow-up. All three modalities have seen continued Page 2 of 5

3 advances, allowing faster scanning and higher-resolution images. They also provide highquality images, non-invasively, matching that of angiography for lumens of large and medium-size vessels. Conventional angiography, however, provides better resolution of smaller, peripheral vessels. Ultrasound provides excellent detail to assess luminal and mural changes in peripheral and superficial vessels. Cross-sectional imaging modalities are useful for demonstrating end-organ involvement and complications of vasculitis. In small-vessel vasculitides where vessel changes are beyond the resolution of all imaging modalities, cross-sectional modalities are useful to evaluate tissue damage in organs. Skin and rheumatology Susan Burge, Rubeta Matin, and Dinny Wallis Print Publication Year: 2016 Published Online: Aug 2016 ISBN: eisbn: DOI: /med/ This chapter describes the clinical features, differential diagnosis, investigation, and management of skin problems associated with rheumatic diseases. Topics include rheumatoid arthritis, lupus erythematosus, dermatomyositis, systemic sclerosis, relapsing polychondritis, multicentric reticulohistiocytosis, and heritable collagen disorders. The approach to investigation of an underlying systemic disease is discussed. The relevance of autoantibody profiles in particular diseases is explained. Ocular manifestations of systemic vasculitis Russell W. Read DOI: /med/ The eyeball and surrounding structures are richly vascularized, supplied by branches from the internal and external carotids. A variety of ocular conditions may be caused by, or associated with, systemic vasculitis and there is potential for profound visual loss. Structures that may be involved are: conjunctiva, cornea, sclera and episclera, uveal tract, retina, orbit, and optic nerves. Examination of the ocular manifestations of vasculitis is important from the perspective of both the ophthalmologist who diagnoses an ocular condition, and must consider whether it is a manifestation of a systemic vasculitis, and the non-ophthalmologist who diagnoses a systemic vasculitis, and seeks to determine if the eye is involved. Because the eye is the only location in the human body in which vasculature can be directly visualized in the natural state, the ophthalmologist s contribution can be both vision preserving and a diagnostic aid to the referring physician. This chapter discusses ocular manifestations organized by ocular anatomy, followed by sections on ocular manifestations of the different systemic vasculitides. Page 3 of 5

4 Diagnostic and classification criteria Dafna D. Gladman, Cheryl F. Rosen, and Vinod Chandran Print Publication Year: 2014 Published Online: Apr 2014 ISBN: eisbn: DOI: /med/ Psoriatic arthritis is diagnosed using the diagnostic criteria first postulated by Moll and Wright. The recently developed CASPAR criteria are used to classify patients with psoriatic arthritis CASPAR criteria have high sensitivity and specificity in both early and established psoriatic arthritis Approach to the diagnosis of vasculitis in adult patients Barri J. Fessler DOI: /med/ Diagnosis of vasculitis is challenging due to non-specific symptoms, overlapping syndromes, lack of specific diagnostic tests, and the absence of generally accepted diagnostic criteria. While progress is being made in establishment of classification criteria for the different vasculitic syndromes (as published by the 2012 Chapel Hill Consensus Conference on nomenclature of vasculitides), there remains a strong need for classification and diagnostic criteria to aid in the early diagnosis of vasculitis and facilitate research studies. The initial, essential step in diagnosis is a comprehensive history and physical examination. The next step is selection of appropriate tests to delineate areas of disease involvement, either through tissue biopsy or imaging studies. At the same time, secondary causes of vasculitis and mimics of vasculitis must be excluded. The demonstration of vasculitis on tissue biopsy remains the gold standard for diagnosis. However, this is often not straightforward and diagnosis of a specific form of vasculitis requires familiarity with the features of the different syndromes and narrowing down the differential diagnosis based on histological, laboratory, and imaging findings in the context of the clinical pattern. Granulomatosis with polyangiitis (Wegener s granulomatosis)clinical and immunodiagnostic aspects Susanne Schinke, Wolfgang L. Gross, and Elena Csernok DOI: /med/ Granulomatosis with polyangiitis is a rare, systemic disorder defined as a necrotizing granulomatous inflammation of the respiratory tract and a necrotizing vasculitis affecting small to medium-sized vessels, with necrotizing glomerulonephritis and pulmonary Page 4 of 5

5 capillaritis but also granulomatous and non-granulomatous extravascular inflammation. Clinical suspicion of GPA should be raised by treatment-refractory chronic or destructive ENT complaints, systemic inflammation, granulomatous disease, or surrogate markers of vasculitis (nephritic sediment or purpura). In localized GPA, the respiratory tract only is affected. The combination of clinical, imaging, and histological findings with ANCA (usually canca/pr3, occasionally panca/mpo) leads to the diagnosis of GPA. However, absence of ANCA does not exclude GPA. Differential diagnoses include other primary ANCA- and non-anca-associated vasculitides and vasculitis mimics: infection, malignancy, non-vasculitic granulomatous diseases (e.g. TAP-deficiency), microangiopathies. The chapter presents established tools for evaluation of disease activity and damage (BVAS, DEI, ENTAS, VDI). Despite a high burden of disease, the outcome has significantly improved due to better diagnosis, disease awareness, and optimized immunosuppression. Nevertheless, mortality is increased, particularly within the first year, in young men, intensive care patients, and in renal or visceral organ involvement. Longterm morbidity is determined by relapsing disease leading to chronic damage, therapy sideeffects, and co-morbidities. Page 5 of 5

Atlas of the Vasculitic Syndromes

Atlas of the Vasculitic Syndromes CHAPTER e40 Atlas of the Vasculitic Syndromes Carol A. Langford Anthony S. Fauci Diagnosis of the vasculitic syndromes is usually based upon characteristic histologic or arteriographic findings in a patient

More information

Scleritis LEN V KOH OD

Scleritis LEN V KOH OD Scleritis LEN V KOH OD 2014 PUCO 1 Introduction A painful, destructive, and potentially blinding disorder Highly symptomatic High association with systemic disease Immunosuppresssive agents 2014 PUCO 2

More information

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology Vasculitis Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology Disease Spectrum Hypersensitivity vasculitis/microscopic

More information

SHO Teaching. Dr. Amir Bhanji Consultant Nephrologist, Q.A hospital, Portsmouth

SHO Teaching. Dr. Amir Bhanji Consultant Nephrologist, Q.A hospital, Portsmouth SHO Teaching Vasculitis Renal medicine Dr. Amir Bhanji Consultant Nephrologist, Q.A hospital, Portsmouth OUTLINE What is vasculitis Causes Classification Brief look into ANCA Associated Vasculitis (AAV)

More information

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis Edward Dwyer, M.D. Division of Rheumatology VASCULITIS is a primary inflammatory disease process of the vasculature Determinants of the Clinical Manifestations of : Target organ involved Size of vessel

More information

Case Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis

Case Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis Case Presentation VASCULITIS The patient is a 24 year old woman who presented to the emergency room with left-sided weakness. She was confused and complained of a severe headache. She was noted to have

More information

Laboratory investigations in gout. Cutaneous small-vessel vasculitis. Oxford Medicine Online

Laboratory investigations in gout. Cutaneous small-vessel vasculitis. Oxford Medicine Online Oxford Medicine Online You are looking at 1-10 of 14 items for: UA MED00360 Laboratory investigations in gout Eliseo Pascual and Francisca Sivera Print Publication Year: 2016 Published Online: Nov 2016

More information

VASCULITIS. Case Presentation. Case Presentation

VASCULITIS. Case Presentation. Case Presentation VASCULITIS Case Presentation The patient is a 24 year old woman who presented to the emergency room with left-sided weakness. She was confused and complained of a severe headache. She was noted to have

More information

Managing Acute Medical Problems, Birmingham Vasculitis. David Jayne. University of Cambridge

Managing Acute Medical Problems, Birmingham Vasculitis. David Jayne. University of Cambridge Managing Acute Medical Problems, Birmingham 2016 Vasculitis David Jayne University of Cambridge Disclosures Astra Zeneca, Aurinia, BIOGEN, Boehringer, Chemocentryx, Genzyme/Sanofi, GSK, Lilly, Medimmune,

More information

Kelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition

Kelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition Kelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition Firestein, G ISBN-13: 9781437717389 Table of Contents VOLUME I STRUCTURE AND FUNCTION OF BONE,

More information

Update - Imaging of the Spondyloarthropathies. Spondyloarthropathies. Spondyloarthropathies

Update - Imaging of the Spondyloarthropathies. Spondyloarthropathies. Spondyloarthropathies Update - Imaging of the Spondyloarthropathies Donald J. Flemming, M.D. Dept of Radiology Penn State Hershey Medical Center Spondyloarthropathies Family of inflammatory arthritides of synovium and entheses

More information

CENTRAL NERVOUS SYSTEM VASCULITIS

CENTRAL NERVOUS SYSTEM VASCULITIS What is central nervous system (CNS) vasculitis? Central nervous system (CNS) vasculitis is among a family of rare disorders characterized by inflammation of the blood vessels, which restricts blood flow

More information

Chapter 2. Overview of ankylosing spondylitis

Chapter 2. Overview of ankylosing spondylitis Chapter 2 Overview of ankylosing spondylitis The concept and classification of spondyloarthritis The term spondyloarthritis (SpA) comprises AS, reactive arthritis, arthritis/spondylitis associated with

More information

PAEDIATRIC VASCULITIS

PAEDIATRIC VASCULITIS PAEDIATRIC VASCULITIS Lawrence Owino Okong o, Mmed (UoN); Mphil. (UCT). Lecturer, Department of Paediatrics and Child Health, University of Nairobi. Paediatrician/ Rheumatologist. OUTLINE Introduction

More information

Vasculitis Prof. Dr. med. Katharina Glatz Pathologie

Vasculitis Prof. Dr. med. Katharina Glatz Pathologie Vasculitis 08-21-2018 Prof. Dr. med. Katharina Glatz Pathologie Agenda Anatomy and histology Vasculitis: Chapel Hill Classification Examples Giant cell arteritis Single organ vasculitis Artery or Vein?

More information

Curricular Components for Rheumatology EPA

Curricular Components for Rheumatology EPA Curricular Components for Rheumatology EPA 1. EPA Title Manage patients with acute or chronic complex multi-system rheumatic disease in an ambulatory, emergency, or inpatient setting. 2. Description of

More information

Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward

Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward VASCULITIS SYNDROMES Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward ILLUSTRATED CASE 1 A 56 years old lady refered me for prolonged fever, arthritis

More information

AN OVERVIEW OF ANCA-ASSOCIATED VASCULITIS

AN OVERVIEW OF ANCA-ASSOCIATED VASCULITIS GRANULOMATOSIS WITH POLYANGIITIS (GPA), MICROSCOPIC POLYANGIITIS (MPA), and EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AN OVERVIEW OF ANCA-ASSOCIATED VASCULITIS What is ANCA-associated Vasculitis?

More information

VASCULITIS AND VASCULOPATHY

VASCULITIS AND VASCULOPATHY VASCULITIS AND VASCULOPATHY Mantosh S. Rattan @CincyKidsRad facebook.com/cincykidsrad Disclosure No relevant financial disclosures Outline Overview Referral pathways MR imaging Case examples Vasculitis

More information

ENFERMEDADES AUTOINMUNES SISTÉMICAS. Dr. J. María Pego Reigosa

ENFERMEDADES AUTOINMUNES SISTÉMICAS. Dr. J. María Pego Reigosa ENFERMEDADES AUTOINMUNES SISTÉMICAS Dr. J. María Pego Reigosa ABSTRACT NUMBER: 888 PHASE 3 TRIAL RESULTS WITH BLISIBIMOD, A SELECTIVE INHIBITOR OF B-CELL ACTIVATING FACTOR, IN SUBJECTS WITH MODERATE-TO-SEVERE

More information

Vasculitis and Vasculitides. OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi

Vasculitis and Vasculitides. OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi Vasculitis and Vasculitides OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi Definition Presence of leucocytes in the vessel wall with reactive damage

More information

ANCA associated vasculitis in China

ANCA associated vasculitis in China ANCA associated vasculitis in China Min Chen Renal Division, Peking University First Hospital, Beijing 100034, P. R. China 1 General introduction of AAV in China Disease spectrum and ANCA type Clinical

More information

Case Presentation. Rafid Asfar, MD

Case Presentation. Rafid Asfar, MD Case Presentation Rafid Asfar, MD Introduction ANCA associated vasculitis may be localized or systemic, and can involve the eyes Ocular manifestations can occur in the absence of systemic disease in persons

More information

Diagnostic Procedures for Vasculitis

Diagnostic Procedures for Vasculitis Diagnostic Procedures for Vasculitis Toshiharu Matsumoto, MD Clinical Professor of Department of Diagnostic Pathology Juntendo University Nerima Hospital, Tokyo, Japan Introduction In 1994, the International

More information

Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation

Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation Marcelo C. Pasquini, MD, MSc HVD05_1.ppt Outline Review of autoimmune diseases (AID). Role of transplantation for AID Data collection:

More information

Small Vessel Vasculitis

Small Vessel Vasculitis Small Vessel Vasculitis Paul A Brogan Professor of Vasculitis and Consultant Paediatric Rheumatologist Department of Rheumatology Institute of Child Health and Great Ormond St Hospital, London UK P.brogan@ucl.ac.uk

More information

Management of Acute Vasculitis. CMT teaching 3 rd June 2015 Caroline Wroe

Management of Acute Vasculitis. CMT teaching 3 rd June 2015 Caroline Wroe Management of Acute Vasculitis CMT teaching 3 rd June 2015 Caroline Wroe Vasculitis pub quiz Match the date with the event Dr Peter McBride, Scottish Otolaryngologist describes a disease of rapid destruction

More information

Vasculitis Update. A selective review of what s new. Dr Jonathan Akikusa MBBS FRACP

Vasculitis Update. A selective review of what s new. Dr Jonathan Akikusa MBBS FRACP Vasculitis Update A selective review of what s new Dr Jonathan Akikusa MBBS FRACP Consultant Paediatric Rheumatologist Royal Children s Hospital, Melbourne Honorary Research Fellow Murdoch Children s Research

More information

Combined Infliximab and Rituximab in Necrotising Scleritis

Combined Infliximab and Rituximab in Necrotising Scleritis This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the article

More information

DEPARTMENT OF RHEUMATOLOGY

DEPARTMENT OF RHEUMATOLOGY DEPARTMENT OF RHEUMATOLOGY PG Teaching Schedule Theory (8 30 am to 9am) DATE TOPIC PRESENTER FACULTY 01/10/16 Approach to Arthritis Dr. Sandeep Dr. Suma Balan 03/10/16 Cardiovascular risk in Rheumatic

More information

Year In Review: VasculitisPers. Disclosures. Learning Objectives. none 4/16/2018. Describe new medications for the treatment of vasculitis

Year In Review: VasculitisPers. Disclosures. Learning Objectives. none 4/16/2018. Describe new medications for the treatment of vasculitis Year In Review: VasculitisPers Cailin Sibley, M.D., M.H.S. Director, Vasculitis Clinic April 27 th, 2018 NTEREST DISCLOSURE Disclosures none Learning Objectives Describe new medications for the treatment

More information

Guideline on the clinical management of Henoch Schonlein Purpura (HSP)

Guideline on the clinical management of Henoch Schonlein Purpura (HSP) Guideline on the clinical management of Henoch Schonlein Purpura (HSP) Purpose To ensure a standardised approach in the management of children with HSP in southern Derbyshire. Scope The scope of this guideline

More information

ArLAR 2018, the Pan Arab Rheumatology Conference in conjunction with the 1st OSR meeting 23 to 25 February 2018, Muscat, Oman.

ArLAR 2018, the Pan Arab Rheumatology Conference in conjunction with the 1st OSR meeting 23 to 25 February 2018, Muscat, Oman. ArLAR 2018, the Pan Arab Rheumatology Conference in conjunction with the 1st OSR meeting 23 to 25 February 2018, Muscat, Oman. to change at any time www.arlar.org info@arlar.org #ArLAR2018 Thursday, 22

More information

Juvenile Chronic Arthritis

Juvenile Chronic Arthritis Juvenile Chronic Arthritis Dr. Christa Visser MBChB MMed (Med Phys) Diploma Musculoskeletal Medicine (UK), Member Society of Orthopaedic Medicine (UK) Childhood Arthritis JCA/JIA/JRA Remember Acute rheumatic

More information

Rheumatology and Internal Diseases Clinic of the Central Clinical Hospital in Warsaw 137 Woloska St. WARSAW POLAND prof. Małgorzata Wisłowska

Rheumatology and Internal Diseases Clinic of the Central Clinical Hospital in Warsaw 137 Woloska St. WARSAW POLAND prof. Małgorzata Wisłowska Rheumatology and Internal Diseases Clinic of the Central Clinical Hospital in Warsaw 137 Woloska St. WARSAW 02-507 POLAND prof. Małgorzata Wisłowska MD, PhD 1 Klinika Chorób Wewnętrznych i Reumatologii

More information

Clinical characteristics and outcome of vasculitides

Clinical characteristics and outcome of vasculitides GENERAL SECTION ORIGINAL ARTICLE Clinical characteristics and outcome of vasculitides Buddhi Prasad Paudyal, 1 Madhu Gyawalee 2 ISSN: 2091-2749 (Print) 2091-2757 (Online) Correspondence Dr. Buddhi Prasad

More information

What is Axial Spondyloarthritis?

What is Axial Spondyloarthritis? Physiotherapist Module 2 What is Axial Spondyloarthritis? How does it apply to physiotherapists? Claire Harris, Senior Physiotherapist, London North West Healthcare NHS Trust Susan Gurden, Advanced Physiotherapy

More information

Lupus and Social Security Disability Programs LISA GONZALEZ GOETZ, PA GONZALEZ & GOETZ, LLC

Lupus and Social Security Disability Programs LISA GONZALEZ GOETZ, PA GONZALEZ & GOETZ, LLC Lupus and Social Security Disability Programs LISA GONZALEZ GOETZ, PA GONZALEZ & GOETZ, LLC SOCIAL SECURITY DISABILITY PROGRAMS Disability Insurance Benefits (Title II) Supplemental Security Income (Title

More information

SMALL TO MEDIUM VASCULITIS: RENAL ASPECT RATANA CHAWANASUNTORAPOJ UPDATE IN INTERNAL MEDICINE 2018

SMALL TO MEDIUM VASCULITIS: RENAL ASPECT RATANA CHAWANASUNTORAPOJ UPDATE IN INTERNAL MEDICINE 2018 SMALL TO MEDIUM VASCULITIS: RENAL ASPECT RATANA CHAWANASUNTORAPOJ UPDATE IN INTERNAL MEDICINE 2018 OUTLINE Renal involvement in vasculitis Curr Rheumatol Rep 2013 Renal involvement in ANCA vasculitis GN***:

More information

A number of factors point to the likelihood of a person with RA developing RV:

A number of factors point to the likelihood of a person with RA developing RV: What is rheumatoid vasculitis (RV)? Rheumatoid vasculitis (RV) is a rare but serious complication of rheumatoid arthritis (RA) an inflammatory disease that causes severe joint pain and damage, and can

More information

AKI Case study -Vasculitis. Sarah Mackie Renal Practice Development Nurse King s College Hospital - London

AKI Case study -Vasculitis. Sarah Mackie Renal Practice Development Nurse King s College Hospital - London AKI Case study -Vasculitis Sarah Mackie Renal Practice Development Nurse King s College Hospital - London What is vasculitis Vasculitis refers to inflammation of the blood vessels, including arteries,

More information

FAQ Identifying and enrolling participants

FAQ Identifying and enrolling participants FAQ Identifying and enrolling participants WHO IS ELIGIBLE - CASES? Patients with a new diagnosis of primary systemic vasculitis Patients suitable as cases are over 18 years with a new presentation or

More information

Vasculitis (Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener s Granulomatosis, Henoch- Schönlein Purpura)

Vasculitis (Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener s Granulomatosis, Henoch- Schönlein Purpura) Vasculitis (Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener s Granulomatosis, Henoch- Schönlein Purpura) J. Charles Jennette Ronald J. Falk The kidneys are affected by a variety of systemic vasculitides

More information

GIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

GIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018. What is giant cell arteritis (GCA)? Giant cell arteritis (GCA) is a form of vasculitis a family of rare disorders characterized by inflammation of the blood vessels, which can restrict blood flow and damage

More information

Case reports CASE 1. A 67-year-old white man had back pain since the age. our clinic several years later with progressive symptoms.

Case reports CASE 1. A 67-year-old white man had back pain since the age. our clinic several years later with progressive symptoms. Annals of the Rheumatic Diseases, 1982, 41, 574-578 Late-onset peripheral joint disease in ankylosing spondylitis MARC D. COHEN AND WILLIAM W. GINSBURG From the Division ofrheumatology and Internal Medicine,

More information

Rheumatoid Arthritis. Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904)

Rheumatoid Arthritis. Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904) Rheumatoid Arthritis Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904) 503-6999. 1 Disclosures Speaker Bureau: Abbvie 2 Objectives Better understand the pathophysiology

More information

Presenting Features in Pakistani Patients Suffering from the Antineutrophil Cytoplasmic Antibody - Classical Subtype (c- ANCA) Associated Vasculitis

Presenting Features in Pakistani Patients Suffering from the Antineutrophil Cytoplasmic Antibody - Classical Subtype (c- ANCA) Associated Vasculitis Presenting Features in Pakistani Patients Suffering from the Antineutrophil Cytoplasmic Antibody - Classical Subtype (c- ANCA) Associated Vasculitis Tahir Aziz Ahmed,Abdul Halim,Tassawar Hussain,Nadeem

More information

TOCILIZUMAB FOR DIFFICULT TO TREAT IDIOPATHIC RETROPERITONEAL FIBROSIS. A PILOT TRIAL

TOCILIZUMAB FOR DIFFICULT TO TREAT IDIOPATHIC RETROPERITONEAL FIBROSIS. A PILOT TRIAL TOCILIZUMAB FOR DIFFICULT TO TREAT IDIOPATHIC RETROPERITONEAL FIBROSIS. A PILOT TRIAL Dr Augusto Vaglio, Dr Federica Maritati Unit of Nephrology, University Hospital of Parma, Via Gramsci 14, 43126 Parma

More information

Done by: Shatha Khtoum

Done by: Shatha Khtoum Done by: Shatha Khtoum Overview Vasculitis -Vasculitis is a general term for vessel wall inflammation -Symptoms and signs depend on the tissue of which the vessels are affected. (slide 2) -There are usually

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A ANCA vasculitis. See Antineutrophil cytoplasmic antibody associated (ANCA) vasculitis Angiography 54 Antineutrophil cytoplasmic antibody correlation

More information

Overview. = inflammation of vessel wall. Symptoms and signs depend on the tissue of which the vessels are affected

Overview. = inflammation of vessel wall. Symptoms and signs depend on the tissue of which the vessels are affected Vasculitis (1+2) Overview = inflammation of vessel wall Symptoms and signs depend on the tissue of which the vessels are affected Often with systemic symptoms fever, myalgia, arthralgia, malaise etc. Most

More information

anti-neutrophil cytoplasmic antibody, myeloperoxidase, microscopic polyangiitis, cyclophosphamide, corticosteroid

anti-neutrophil cytoplasmic antibody, myeloperoxidase, microscopic polyangiitis, cyclophosphamide, corticosteroid Online publication June 24, 2009 ANCA JMAAV 1 2 ANCA JMAAV MPO-ANCA 18 17 50 J Jpn Coll Angiol, 2009, 49: 53 61 anti-neutrophil cytoplasmic antibody, myeloperoxidase, microscopic polyangiitis, cyclophosphamide,

More information

Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? COPYRIGHT

Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? COPYRIGHT Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center Boston, MA Diagnostic Tests in Rheumatic Disease: What's Old,

More information

Annual Rheumatology & Therapeutics Review for Organizations & Societies

Annual Rheumatology & Therapeutics Review for Organizations & Societies Annual Rheumatology & Therapeutics Review for Organizations & Societies Update on Granulomatosis with Polyangiitis (Wegener s) Learning Objectives Identify the clinical features of granulomatosis with

More information

Vasculitides in Surgical Neuropathology Practice

Vasculitides in Surgical Neuropathology Practice Vasculitides in Surgical Neuropathology Practice USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS

More information

Applications of PET/CT in Rheumatology. Role of PET/CT. Annibale Versari, MD Nuclear Medicine PET Center S.Maria Nuova Hospital Reggio Emilia Italy

Applications of PET/CT in Rheumatology. Role of PET/CT. Annibale Versari, MD Nuclear Medicine PET Center S.Maria Nuova Hospital Reggio Emilia Italy CME Session Associazione Italiana di Medicina Nucleare ed Imaging Molecolare Applications of PET/CT in Rheumatology Role of PET/CT Annibale Versari, MD Nuclear Medicine PET Center S.Maria Nuova Hospital

More information

Optical coherence tomography findings in a child with posterior scleritis

Optical coherence tomography findings in a child with posterior scleritis European Journal of Ophthalmology / Vol. 18 no. 6, 2008 / pp. 1007-1010 SHORT OMMUNITIONS & SE REPORTS Optical coherence tomography findings in a child with posterior scleritis H. ERDÖL, M. KOL,. TÜRK

More information

ESIM Winter School 2014 Case Presentation

ESIM Winter School 2014 Case Presentation ESIM Winter School 2014 Case Presentation Hacettepe University School of Medicine Ankara/Turkey Ozant Helvaci, M.D. Patient T.K., 59 years old, male, married with one child, unemployed, place of birth/

More information

Articular disease of the hand - the target joint approach

Articular disease of the hand - the target joint approach Articular disease of the hand - the target joint approach Poster No.: C-1817 Congress: ECR 2016 Type: Educational Exhibit Authors: R. R. Domingues Madaleno 1, A. P. Pissarra 1, I. Abreu 2, A. Canelas 1,

More information

Vasculitis local: systemic

Vasculitis local: systemic Vasculitis Inflammation of the vessel wall. Signs and symptoms: 1- local: according to the involved tissue 2- systemic:(fever, myalgia, arthralgias, and malaise) Pathogenesis 1- immune-mediated inflammation

More information

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies Sarah Goglin MD Assistant Professor of Medicine Division of Rheumatology Disclosures None 1 [footer

More information

37 year old male with several year history of back pain

37 year old male with several year history of back pain 37 year old male with several year history of back pain Inflammatory Low Back Pain Clues onset before the age of 40 years insidious onset, chronic (>3 months) pain morning stiffness for longer than 30

More information

Vasculitis local: systemic

Vasculitis local: systemic Vasculitis Inflammation of the vessel wall. Signs and symptoms: 1- local: according to the involved tissue 2- systemic:(fever, myalgia, arthralgias, and malaise) Pathogenesis 1- immune-mediated 2- infectious

More information

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center RHEUMATOLOGY OVERVIEW Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center What is Rheumatology? Medical science devoted to the rheumatic diseases

More information

When to suspect Wegener Granulomatosis: A radiologic review

When to suspect Wegener Granulomatosis: A radiologic review When to suspect Wegener Granulomatosis: A radiologic review Poster No.: P-0038 Congress: ESTI 2015 Type: Educational Poster Authors: A. Tilve Gómez, R. Díez Bandera, P. Rodríguez Fernández, M. Garcia Vazquez-Noguerol,

More information

Sine Syndromes in Rheumatology

Sine Syndromes in Rheumatology Sine Syndromes in Rheumatology Jozef Rovenský Manfred Herold Martina Vašáková Editors Sine Syndromes in Rheumatology Editors Jozef Rovenský National Institute of Rheumatic Diseases Piešťany Slovakia Institute

More information

Autoantibodies in the Idiopathic Inflammatory Myopathies

Autoantibodies in the Idiopathic Inflammatory Myopathies Autoantibodies in the Idiopathic Inflammatory Myopathies Steven R. Ytterberg, M.D. Division of Rheumatology Mayo Clinic Rochester, MN The Myositis Association Annual Conference St. Louis, MO Sept. 25,

More information

Small Vessel Vasculitis

Small Vessel Vasculitis Banff- Rocky Mountain Barry Kassen, MD, FRCPC,FACP Head, Division of Internal Medicine UBC/VGH/SPH Acting Head, Division of Community Internal Medicine November, 2009 Objectives 1. To understand small

More information

December 6, 2010 Asthma and Rheumatic Disorders and Vasculitis

December 6, 2010 Asthma and Rheumatic Disorders and Vasculitis December 6, 2010 Asthma and Rheumatic Disorders and Vasculitis Lanny J. Rosenwasser, M.D. Dee Lyons/Missouri Endowed Chair in Immunology Research Professor of Pediatrics Allergy-Immunology Division Childrens

More information

Tell me more about vasculitis. Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital

Tell me more about vasculitis. Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital Tell me more about vasculitis Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital Talk overview Case study ANCA-associated vasculitis What is ANCA vasculitis? What causes ANCA

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval LL - LL-ROHINI (NATIONAL REFERENCE 135091593 Age 25 Years Gender Male 30/8/2017 91600AM 30/8/2017 93946AM 31/8/2017 84826AM Ref By Final COLLAGEN DISEASES ANTIBODY ANEL ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF),

More information

Preventing blindness: Ultrasound in Giant cell arteritis

Preventing blindness: Ultrasound in Giant cell arteritis Preventing blindness: Ultrasound in Giant cell arteritis Elizabeth Jernberg, MD Associate Clinical Professor of Medicine Division of Rheumatology University of Washington Virginia Mason Medical Center

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Proposed Health Technology Appraisal Secukinumab for treating ankylosing spondylitis after inadequate response to non-steroidal anti-inflammatory drugs

More information

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J. Making Room for Rheumatology James J. Nocton, MD Disclosures I have nothing to disclose Rheumatic Diseases of Childhood Juvenile Idiopathic Arthritis (JIA) Systemic Lupus Erythematosus (SLE) Juvenile Dermatomyositis

More information

www.fisiokinesiterapia.biz Peak onset between 20 and 30 years Form of spondyloarthritis (cause inflammation around site of ligament insertion into bone) and association with HLA-B27 Prevalence as high

More information

TREATMENT OF ANCA-ASSOCIATED VASCULITIS

TREATMENT OF ANCA-ASSOCIATED VASCULITIS TREATMENT OF ANCA-ASSOCIATED VASCULITIS Loïc Guillevin Hôpital Cochin, Université Paris Descartes Cours DU, 11 mars 2016 1 Disclosure of interest regarding this presentation Roche has provided, in part,

More information

EUVAS update June 5 th Marinka Twilt

EUVAS update June 5 th Marinka Twilt EUVAS update June 5 th 2012 Marinka Twilt Chapel Hill 2012 Classification Large Vessel Vasculitis (LVV) Medium Vessel Vasculitis (MVV) Small Vessel Vasculitis (SVV) Variable Vessel Vasculitis (VVV) Single

More information

Clinical Commissioning Policy: Rituximab For ANCA Vasculitis. December Reference : NHSCB/ A3C/1a

Clinical Commissioning Policy: Rituximab For ANCA Vasculitis. December Reference : NHSCB/ A3C/1a Clinical Commissioning Policy: Rituximab For ANCA Vasculitis December 2012 Reference : NHSCB/ A3C/1a NHS Commissioning Board Clinical Commissioning Policy: Rituximab For The Treatment Of Anti-Neutrophil

More information

Imaging and intervention of sacroiliac joint. Dr Ryan Lee Ka Lok Associate Consultant Prince of Wales Hospital

Imaging and intervention of sacroiliac joint. Dr Ryan Lee Ka Lok Associate Consultant Prince of Wales Hospital Imaging and intervention of sacroiliac joint Dr Ryan Lee Ka Lok Associate Consultant Prince of Wales Hospital Introduction 15%-25% of low back pain is related to sacroiliac joint (SIJ) pain SIJ pain is

More information

VCRC-OMERACT ANCA-Vasculitis Outcome Measure Initiative Comparative Outcome Measure Exercise-Training Cases

VCRC-OMERACT ANCA-Vasculitis Outcome Measure Initiative Comparative Outcome Measure Exercise-Training Cases Introduction to Training Cases The purpose of this preliminary exercise is to familiarize you with the rules and logistics of the five instruments under study. Please do not read the Training Cases until

More information

Vasculitis of the peripheral nervous system

Vasculitis of the peripheral nervous system 4 rd Congress of the European Academy of Neurology Lisbon, Portugal, June 16-19, 2018 Teaching Course 5 Acute emergencies in neuromuscular disease - Level 2 Vasculitis of the peripheral nervous system

More information

Arthritis & Rheumatism DOI /art.00000

Arthritis & Rheumatism DOI /art.00000 Special DOI 10.1002/art.00000 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross

More information

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING AUTOIMMUNE DISORDERS IN THE ACUTE SETTING Diagnosis and Treatment Goals Aimee Borazanci, MD BNI Neuroimmunology Objectives Give an update on the causes for admission, clinical features, and outcomes of

More information

2004 Health Press Ltd.

2004 Health Press Ltd. ... Ankylosing spondylitis Maxime Dougados MD Professor of Rheumatology Hôpital Cochin René Descartes University Paris, France Désirée van der Heijde MD PhD Professor of Rheumatology University Hospital

More information

What will we discuss today?

What will we discuss today? Autoimmune diseases What will we discuss today? Introduction to autoimmune diseases Some examples Introduction to autoimmune diseases Chronic Sometimes relapsing Progressive damage Epitope spreading more

More information

T he primary systemic vasculitides (PSV) are clinically

T he primary systemic vasculitides (PSV) are clinically 605 EXTENDED REPORT EULAR recommendations for conducting clinical studies and/ or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis Bernhard Hellmich,

More information

The many faces of extranodal lymphoma

The many faces of extranodal lymphoma The many faces of extranodal lymphoma Frank Pameijer Departments of Radiology and Radiation Oncology University Medical Center Utrecht Special thanks to Ilona M Schmalfuss, MD University of Florida Gainesville,

More information

Rheumatology Residency Rotation University of Colorado Health Sciences Center

Rheumatology Residency Rotation University of Colorado Health Sciences Center 2010 Rheumatology Residency Rotation University of Colorado Health Sciences Center This paragraph only applies if you are rotating at the University of Colorado Hospital. Please review the rest of the

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval 135091662 Age 45 Years Gender Male 29/8/2017 120000AM 29/8/2017 100215AM 29/8/2017 110825AM Ref By Final RHEUMATOID AUTOIMMUNE COMREHENSIVE ANEL ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF), SERUM ----- 20-60

More information

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION European Medicines Agency London, 20 September 2007 Product name: Remicade Procedure number: EMEA/H/C/240/II/95 SCIENTIFIC DISCUSSION 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20)

More information

Jeopardy. What s the rash? $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400

Jeopardy. What s the rash? $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400 Jeopardy Antibodies & more antibodies Aching joints What s the rash? Potpourri Image Challenge $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400 $500 $500

More information

a mimicker of Wegener s Granulomatosis

a mimicker of Wegener s Granulomatosis a mimicker of Wegener s Granulomatosis Combined Meeting October 2009 a story of 2 ladies Madam JA 56 year-old Madam RH 36 year-old Madam JA 56 year-old Apr 2008 May Jun Jul Aug Sept Oct Nov 2008 Madam

More information

TAKAYASU S ARTERITIS. Second-stage symptoms include:

TAKAYASU S ARTERITIS. Second-stage symptoms include: What is Takayasu s arteritis (TAK)? Takayasu s arteritis (TAK) is a form of vasculitis a family of rare disorders characterized by inflammation of the blood vessels, which can restrict blood flow and damage

More information

8/29/2012. Outline Juvenile idiopathic arthritis. 1. Classification-ILAR. 1. Classification-clinical diagnosis. 1. JIA classification

8/29/2012. Outline Juvenile idiopathic arthritis. 1. Classification-ILAR. 1. Classification-clinical diagnosis. 1. JIA classification Outline Juvenile idiopathic arthritis 1. Classification and symptoms (ILAR-International league of Associations for Rheumatology) 2. Imaging J. Herman Kan, M.D. Section chief, musculoskeletal imaging Edward

More information

Protocol Version 2.0 Synopsis

Protocol Version 2.0 Synopsis Protocol Version 2.0 Synopsis Title Short Title Plasma exchange and glucocorticoid dosing in anti-neutrophil cytoplasm antibody associated vasculitis: a randomized controlled trial. PEXIVAS PEXIVAS Clinical

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval 135091660 Age 44 Years Gender Male 29/8/2017 120000AM 29/8/2017 100219AM 29/8/2017 105510AM Ref By Final EXTRACTABLENUCLEAR ANTIGENS (ENA), QUANTITATIVE ROFILE CENTROMERE ANTIBODY, SERUM 20-30 Weak ositive

More information

Review Article. Current concepts in Anti-Neutrophil Cytoplasmic Antibody (ANCA) associated Vasculitis. Milind Aurangabadkar

Review Article. Current concepts in Anti-Neutrophil Cytoplasmic Antibody (ANCA) associated Vasculitis. Milind Aurangabadkar Review Article Vidarbha Journal of Internal Medicine Volume 23 July 207 Current concepts in Anti-Neutrophil Cytoplasmic Antibody (ANCA) associated Vasculitis Milind Aurangabadkar ABSTRACT Anti-neutrophil

More information

Rituximab treatment for ANCA-associated vasculitis in childhood

Rituximab treatment for ANCA-associated vasculitis in childhood Rituximab treatment for ANCA-associated vasculitis in childhood DISCLOSURE I have no relevant financial relationships to disclose Katharine Moore MD Nov 14, 2012 University of Colorado School of Medicine

More information